1h Free Analyst Time
The erectile dysfunction (ED) drugs market is forecasted to grow by USD 1.43 billion during 2023-2028, accelerating at a CAGR of 6.67% during the forecast period. The report on the erectile dysfunction (ED) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for ED drugs, rising awareness of ED, and high prevalence of conditions resulting in ED.
The erectile dysfunction (ED) drugs market is segmented as below:
By End-user
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy
By Product
- Oral drugs
- Topical drugs
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the erectile dysfunction (ED) drugs market covers the following areas:
- Erectile dysfunction (ED) drugs market sizing
- Erectile dysfunction (ED) drugs market forecast
- Erectile dysfunction (ED) drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global erectile dysfunction (ED) drugs market: Bayer AG, Cadila Pharmaceuticals Ltd., Cipla Ltd., Dong A Socio Holdings Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Futura Medical plc, Innovcare Lifesciences Pvt. Ltd., Lupin Ltd., Pfizer Inc., SK Inc., Teva Pharmaceutical Industries Ltd., TTK Healthcare Ltd., Viatris Inc., and VIVUS LLC.Commenting on the report, an analyst from the publisher said: 'The latest trend gaining momentum in the market is presence of novel drug formulations in late stages of development.'
According to the report, one of the major drivers for this market is the rising demand for ED drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- Cadila Pharmaceuticals Ltd.
- Cipla Ltd.
- Dong A Socio Holdings Co. Ltd.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Endo International Plc
- Futura Medical plc
- Innovcare Lifesciences Pvt. Ltd.
- Lupin Ltd.
- Pfizer Inc.
- SK Inc.
- Teva Pharmaceutical Industries Ltd.
- TTK Healthcare Ltd.
- Viatris Inc.
- VIVUS LLC
